Hospice Admission Quotas: Census Bonuses and Overridden Clinical Decisions

Hospice admission quotas become hospice fraud when management pushes staff to admit or retain ineligible patients and bill Medicare for their care. The pressure can reach the nurse writing the assessment, the physician receiving it and the manager deciding whether a patient leaves. If you have watched a clinical objection disappear while the census target stayed in place, you may know how the claim was made possible.

Why a Hospice Census Target Reaches the Patient Chart

Medicare pays routine hospice care by the enrolled day. That makes the census, the number of patients on service, a revenue concern as well as a clinical one. An admission adds paid days. Delaying discharge can keep those payments coming after staff have concluded that the patient no longer qualifies. Taxpayers fund the unsupported care, while the patient’s health care decisions follow a false terminal prognosis.

The economics are particularly strong in the middle of a stay. Care is generally more intensive at admission and near death, with fewer services between them. In its March 2026 hospice report, the Medicare Payment Advisory Commission explains that this makes longer stays more profitable. The same report says providers can use diagnosis and location to identify patients likely to have those longer stays.

An earlier HHS Office of Inspector General study, Medicare Hospices Have Financial Incentives to Provide Care in Assisted Living Facilities, examined Medicare hospice claims from 2007 through 2012. It found longer stays, higher payments and diagnoses typically requiring less complex care among assisted-living residents. Its explanation of the incentive was blunt:

Medicare later changed routine payment to a higher rate for the first 60 days and a lower rate afterward. That change took effect in January 2016. The underlying payment unit remains the enrolled day. A manager trying to protect that revenue can put pressure on both ends of the roster: bringing patients in and keeping them there.

The Medicare annual aggregate cap adds another incentive. It ties a hospice’s total payment ceiling to its beneficiary count, with whole or fractional shares allocated across hospices and cap years. New admissions can raise that ceiling and reduce the amount the hospice must repay.

Who Determines Eligibility for Hospice?

A hospice physician certifies hospice eligibility using the patient’s clinical information. The patient’s own attending doctor also certifies at the start, if the patient has one. The physician’s narrative must describe that patient’s condition.

Hospice eligibility turns on a prognosis of six months or less if the illness runs its normal course. A patient can continue receiving hospice care beyond the initial prognosis when the clinical information supports recertification. Before the third benefit period, around day 180, and each recertification after that, a hospice physician or nurse practitioner must conduct a face-to-face encounter to gather current clinical information.

The admission also changes who pays for care related to the terminal illness. Medicare generally pays the chosen hospice for that care instead of paying other providers separately. An unsupported enrollment can therefore affect the patient’s access to other coverage while the hospice collects its daily payment.

How Census Bonuses Reach Admission and Discharge Decisions

A hospice census bonus tied to admitting ineligible patients connects compensation to an unsupported Medicare claim. The civil cases show how that connection can run through several jobs: the marketer seeking an admission, the nurse assessing the patient and the executive responsible for the census.

Hospice Care of Kansas and Pay Tied to the Census

Hospice Care of Kansas settled for $6.1 million in 2012 over allegations that it billed for patients without a terminal prognosis. The Department of Justice alleged that clinical employees’ compensation depended on census and admissions, that the hospice delayed discharging patients who no longer qualified, and that staff received instructions to document patients’ conditions misleadingly.

A former nurse brought the case. The alleged incentive reached the people creating the clinical evidence used to support payment.

Good Shepherd and Bonuses Across the Admission Chain

Good Shepherd Hospice’s $4 million settlement in 2015 addressed allegations that it billed for patients without a terminal prognosis. The government alleged pressure to meet admissions and census targets, with enrollment-based bonuses for marketers, admissions nurses and executive directors.

Those roles sit at different points in the admission process. The alleged bonus system rewarded each for the same result: another patient enrolled. The Department of Justice also alleged inadequate eligibility training and the selection of medical directors for their ability to refer patients, particularly through nursing-home ties.

Evercare’s Census and the Decision to Keep a Patient

Evercare Hospice agreed to an $18 million settlement in 2016 over allegations that it billed for patients whose records did not support terminal illness. The government alleged practices that discouraged appropriate discharge and failed to ensure accurate nursing documentation.

The government’s consolidated complaint alleged that at most Evercare locations, employees needed the site manager’s involvement and approval to deny a referred patient admission. It also alleged bonuses based on admissions and census. In that alleged system, rejecting a referral required approval from a manager with a census to maintain. In one patient account about continued enrollment, the complaint quoted a management instruction recorded in the medical chart:

In that account, the patient stayed because the census was low. A benefit for terminally ill patients had become a way to fill a revenue gap. For an insider, that alleged instruction connects the business target directly to a patient’s continued enrollment.

Hospice Admission Quota and Medical Director Override

A hospice admission quota can produce a medical director override through pressure on the physician, restricted involvement or control of the information reaching the physician. The original assessment and the packet used for certification can reveal how management changed the decision.

Hospice of the Comforter settled for $3 million in 2013 to resolve allegations that it billed Medicare for ineligible patients. The government alleged that it directed staff to admit all referred patients regardless of eligibility, falsified medical records, limited physicians’ role in assessing terminal status and delayed discharge. The allegations also included using field nurses without hospice training. The company allegedly expanded admissions while weakening the clinical review those admissions required.

The government’s 2021 complaint announcement concerning Curo Health Services described another way to control the result. It alleged that certifying physicians did not receive or adequately consider complete and accurate patient information. The account joined admission pressure, discouraged discharges and internal warnings with continued billing and retained payments. Those allegations later formed part of a broader settlement announced in 2024.

The certification signature shows who approved the prognosis. The assessment, omitted information, review messages and earlier chart versions show what went into it. An insider may know that the physician received a description of decline after the nurse had documented improvement.

What Evidence Is Needed to Prove Fraud?

The evidence connects the target, the patient, the clinical decision and the Medicare claim. A compensation plan explains what management rewarded. An original assessment shows what the clinician observed. The certification packet, later edits and billing history show how the organization turned that assessment into payment.

Different employees see different parts of that sequence. Admissions staff know the conversion goals. Nurses know the patient’s condition. Clinical managers see review meetings and repeated instructions. Finance and compliance staff see the warnings and what happened to the money afterward.

A rejected assessment followed by an admission, or a discharge recommendation followed by another bill, gives those employees a concrete decision to explain. We assess how their account connects management’s instructions to the patient record and the payments.

At Creekside Hospice, the Department of Justice alleged that staff changed records after billing to make the claims appear payable and made physician visits appear to have happened. The alleged changes reached back to support claims already submitted.

Caris Healthcare’s 2018 settlement addressed allegations of continued billing and retained overpayments after its own audits, nurses and chief medical officer raised eligibility concerns. Finance and compliance staff may know what management did after those warnings.

The same review can reveal false visit records or an unsupported level of hospice billing. Routine care pays by the enrolled day, while higher care levels depend on the patient’s needs and the services provided. We connect the specific admission, documentation or service problem to the claim it produced.

A hospice whistleblower can bring the inside account that connects these decisions. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When Admission Pressure Includes Bought Referrals

Internal census pressure and payments for hospice referrals can meet in the same admission. The internal bonus plan shows what the healthcare business wanted its employees to do. A referral agreement, stipend or payment to a facility shows what it gave someone for sending the patient.

Good Shepherd’s alleged selection of medical directors for their nursing-home connections makes that overlap concrete. The physician could be part of the clinical approval process and a source of new patients. The director’s agreement, actual duties, referral pattern and reason for being selected help explain which role the hospice was rewarding.

For the employee who sees only the admission target, the rest of the relationship may be outside their department. We work through how the referral arrived, who approved the admission and what the patient information supported. That connects the commercial arrangement to the clinical decision and the Medicare claim.

When the Census Target Overruled the Assessment

If you saw a patient admitted over a clinical objection or kept on service to protect the census, speak to one of our whistleblower experts about how management made that decision. We build your strongest hospice whistleblower case around the connection between the target, the patient record and the Medicare payments, and bring in hospice fraud whistleblower lawyers who understand admission and recertification cases. We stay beside you from that first account through the case.